sábado, 13 de diciembre de 2025
Trump Weighs Reclassifying Pot; Study Cites Scant Benefit In Medical Use
Trump Weighs Reclassifying Pot; Study Cites Scant Benefit In Medical Use
Cannabis is currently a Schedule 1 substance, on par with heroin and LSD. Reclassifying it as a Schedule III drug would put it in the same category as mild prescription painkillers. The change would ease barriers to research, The Washington Post reports.
https://kffhealthnews.org/morning-breakout/trump-weighs-reclassifying-pot-study-cites-scant-benefit-in-medical-use/
Suscribirse a:
Enviar comentarios (Atom)


No hay comentarios:
Publicar un comentario